Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment
Objective: to study the breast cancer phenotype (ER/PR, FOXA1, HER2, Ki67) and the dynamics of changes in these markers in the tumour before and after neoadjuvant chemotherapy (NAT), compare them with metastases in the regional lymph nodes (LN). Materials and methods. The subject of the study was a...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe / Cruthaithe: |
Remedium Group LLC
2018-07-01
|
| Sraith: | Медицинский совет |
| Ábhair: | |
| Rochtain ar líne: | https://www.med-sovet.pro/jour/article/view/2547 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|